Regeneron, week 6 of the buy signal: profit above 25%
Regeneron stock climbs 3.8% near its highs as the buy signal starts to fade
Our view last week
After the surge two weeks ago, Regeneron stock adds another 2.4% and keeps stringing together higher lows on the daily chart, with buyers still running 78% of volume. The stock is now pressing against its recent high, in the 816 area, while the buy signal - in its fifth week and up more than 20% - starts showing the first signs of fatigue. Today's technical analysis follows exactly that shift, from a run to active management.
This week's summary
The fourth straight higher low, from the 747 area to the 793 area, confirms Regeneron stock keeps stringing gains together step by step: this week the stock adds another 3.8% and presses back against its recent highs. Buyers are still in charge, but three warnings shadow today's technical analysis — contracting volumes, fading body conviction, buyer dominance easing off — right as the buy signal, in week 6 and up more than 25%, shows the first signs of fatigue already flagged seven days ago.
IQS Phase
59
ordinary
Signal Strength
55
medium
Sizing
STANDARD
Ranking
#77 / 167
US stocks in progress
Trade P&L %
+25.51%
from signal to date, no stop loss
Rank position
ranks 77th among the 167 Longs already running for US stocks in our ranking, with a signal strength of 55 out of 100.
Sector context
SectorHealth Care
Benchmark ETFXLV
Sector regimein strong phase
Performanceweekly +4.33% · monthly +9.53%
REGN belongs to the health care sector (reference ETF XLV). The sector is classified in strong phase according to our weekly reading.
restricted Platinum content